THE WHAT? The Estée Lauder Companies (ELC) has announced that Olivier Bottrie is set to retire from his position as Global President Travel Retail and Retail Development, effective 30 June, 2022.
THE DETAILS ELC will announce Bottrie’s successors over the coming days, for both Travel Retail and Retail Development, with the exec working closely with the new hires starting in May.
Bottrie joined ELC 26 years ago, and has been head of ELC’s global Travel Retail business since 2004.
ELC said in a statement, “Throughout his career, Olivier has embraced the power of transformation and championed the first-to-market advantage, recognizing early the opportunity in marketing to the Chinese traveling consumer globally as well as seizing upon the online pre-tail opportunity to unlock growth.”
THE WHY? Leaving the company for retirement, William P. Lauder, Executive Chairman, praised Bottrie’s leadership.
He said, “We are grateful for Olivier’s tremendous contributions to our business over the past 26 years, and the many ground-breaking initiatives he has led for Travel Retail and the company.
“With his empathetic and inclusive leadership style, Olivier has made an enormous difference both within and beyond ELC through his passion for giving back. On behalf of the company and the Lauder family, I would like to wish Olivier the very best in his well-deserved retirement.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
